NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

Eisai: Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anti-Cancer Agent Lenvima (Lenvatinib) With Prospective Indication for Uterine Body Cancer

  • Written by ACN Newswire

image

TOKYO, Mar 12, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally available multiple receptor kinase inhibitor discovered by Eisai, with a prospective indication for uterine body cancer, by the Ministry of Health, Labour and Welfare...

Read more: Eisai: Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to...